
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance
David H. Munn, Andrew L. Mellor
Trends in Immunology (2016) Vol. 37, Iss. 3, pp. 193-207
Open Access | Times Cited: 860
David H. Munn, Andrew L. Mellor
Trends in Immunology (2016) Vol. 37, Iss. 3, pp. 193-207
Open Access | Times Cited: 860
Showing 1-25 of 860 citing articles:
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 7-24
Closed Access | Times Cited: 1973
Stefanie K. Wculek, Francisco J. Cueto, Adriana M. Mujal, et al.
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 7-24
Closed Access | Times Cited: 1973
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten, Ellen A. A. Nollen, Ute F. Röhrig, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 5, pp. 379-401
Open Access | Times Cited: 1113
Michael Platten, Ellen A. A. Nollen, Ute F. Röhrig, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 5, pp. 379-401
Open Access | Times Cited: 1113
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Andrew L. Ji, Adam J. Rubin, Kim Thrane, et al.
Cell (2020) Vol. 182, Iss. 2, pp. 497-514.e22
Open Access | Times Cited: 782
Andrew L. Ji, Adam J. Rubin, Kim Thrane, et al.
Cell (2020) Vol. 182, Iss. 2, pp. 497-514.e22
Open Access | Times Cited: 782
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 607
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 607
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 599
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 599
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Ashley Maynard, Caroline E. McCoach, Julia Rotow, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1232-1251.e22
Open Access | Times Cited: 528
Ashley Maynard, Caroline E. McCoach, Julia Rotow, et al.
Cell (2020) Vol. 182, Iss. 5, pp. 1232-1251.e22
Open Access | Times Cited: 528
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast, William P. Malachowski, James B. DuHadaway, et al.
Cancer Research (2017) Vol. 77, Iss. 24, pp. 6795-6811
Open Access | Times Cited: 481
George C. Prendergast, William P. Malachowski, James B. DuHadaway, et al.
Cancer Research (2017) Vol. 77, Iss. 24, pp. 6795-6811
Open Access | Times Cited: 481
cGAS-STING, an important pathway in cancer immunotherapy
Minlin Jiang, Peixin Chen, Lei Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 413
Minlin Jiang, Peixin Chen, Lei Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 413
Type I Interferon in Chronic Virus Infection and Cancer
Laura M. Snell, Tracy L. McGaha, David G. Brooks
Trends in Immunology (2017) Vol. 38, Iss. 8, pp. 542-557
Open Access | Times Cited: 405
Laura M. Snell, Tracy L. McGaha, David G. Brooks
Trends in Immunology (2017) Vol. 38, Iss. 8, pp. 542-557
Open Access | Times Cited: 405
Is autoimmunity the Achilles' heel of cancer immunotherapy?
Carl H. June, Jeremy Warshauer, Jeffrey A. Bluestone
Nature Medicine (2017) Vol. 23, Iss. 5, pp. 540-547
Closed Access | Times Cited: 404
Carl H. June, Jeremy Warshauer, Jeffrey A. Bluestone
Nature Medicine (2017) Vol. 23, Iss. 5, pp. 540-547
Closed Access | Times Cited: 404
Dendritic Cells and Their Role in Immunotherapy
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 391
Alycia Gardner, Álvaro de Mingo Pulido, Brian Ruffell
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 391
The secretion profile of mesenchymal stem cells and potential applications in treating human diseases
Yuyi Han, Jianxin Yang, Jiankai Fang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 382
Yuyi Han, Jianxin Yang, Jiankai Fang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 382
Recent advances in nanomaterial-based synergistic combination cancer immunotherapy
Wei Sang, Zhan Zhang, Yunlu Dai, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 14, pp. 3771-3810
Closed Access | Times Cited: 349
Wei Sang, Zhan Zhang, Yunlu Dai, et al.
Chemical Society Reviews (2019) Vol. 48, Iss. 14, pp. 3771-3810
Closed Access | Times Cited: 349
Targeting the IDO1 pathway in cancer: from bench to bedside
Ming Liu, Xu Wang, Lei Wang, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 348
Ming Liu, Xu Wang, Lei Wang, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 348
Immunometabolism and natural killer cell responses
Katie L. O’Brien, David K. Finlay
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 282-290
Closed Access | Times Cited: 348
Katie L. O’Brien, David K. Finlay
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 282-290
Closed Access | Times Cited: 348
IDO1 in cancer: a Gemini of immune checkpoints
Lijie Zhai, Erik Ladomersky, Alicia Lenzen, et al.
Cellular and Molecular Immunology (2018) Vol. 15, Iss. 5, pp. 447-457
Open Access | Times Cited: 347
Lijie Zhai, Erik Ladomersky, Alicia Lenzen, et al.
Cellular and Molecular Immunology (2018) Vol. 15, Iss. 5, pp. 447-457
Open Access | Times Cited: 347
Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Mengyu Chang, Zhiyao Hou, Man Wang, et al.
Advanced Materials (2020) Vol. 33, Iss. 4
Closed Access | Times Cited: 347
Mengyu Chang, Zhiyao Hou, Man Wang, et al.
Advanced Materials (2020) Vol. 33, Iss. 4
Closed Access | Times Cited: 347
Photosensitizer Micelles Together with IDO Inhibitor Enhance Cancer Photothermal Therapy and Immunotherapy
Jinrong Peng, Yao Xiao, Wenting Li, et al.
Advanced Science (2018) Vol. 5, Iss. 5
Open Access | Times Cited: 335
Jinrong Peng, Yao Xiao, Wenting Li, et al.
Advanced Science (2018) Vol. 5, Iss. 5
Open Access | Times Cited: 335
Unique roles of tryptophanyl-tRNA synthetase in immune control and its therapeutic implications
Mirim Jin
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 1, pp. 1-10
Open Access | Times Cited: 330
Mirim Jin
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 1, pp. 1-10
Open Access | Times Cited: 330
Tryptophan metabolism in health and disease
Xue Chen, Ganglei Li, Qiuxian Zheng, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1304-1326
Open Access | Times Cited: 317
Xue Chen, Ganglei Li, Qiuxian Zheng, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1304-1326
Open Access | Times Cited: 317
Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer
Jung‐Eun Jang, Cristina Hajdu, Caroline Liot, et al.
Cell Reports (2017) Vol. 20, Iss. 3, pp. 558-571
Open Access | Times Cited: 315
Jung‐Eun Jang, Cristina Hajdu, Caroline Liot, et al.
Cell Reports (2017) Vol. 20, Iss. 3, pp. 558-571
Open Access | Times Cited: 315
Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
Bin Ji, Minjie Wei, Bin Yang
Theranostics (2021) Vol. 12, Iss. 1, pp. 434-458
Open Access | Times Cited: 315
Bin Ji, Minjie Wei, Bin Yang
Theranostics (2021) Vol. 12, Iss. 1, pp. 434-458
Open Access | Times Cited: 315
Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells
Min Hee Oh, Im‐Hong Sun, Liang Zhao, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3865-3884
Open Access | Times Cited: 312
Min Hee Oh, Im‐Hong Sun, Liang Zhao, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 7, pp. 3865-3884
Open Access | Times Cited: 312
STING: a master regulator in the cancer-immunity cycle
Yuanyuan Zhu, Xiang An, Xiao Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 305
Yuanyuan Zhu, Xiang An, Xiao Zhang, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 305
Depression in cancer: The many biobehavioral pathways driving tumor progression
Beatrice Bortolato, Thomas Hyphantis, Sara Valpione, et al.
Cancer Treatment Reviews (2016) Vol. 52, pp. 58-70
Open Access | Times Cited: 302
Beatrice Bortolato, Thomas Hyphantis, Sara Valpione, et al.
Cancer Treatment Reviews (2016) Vol. 52, pp. 58-70
Open Access | Times Cited: 302